{
  "trial_id": "NCT00703079",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "first-line surgery via trans-sphenoidal route by microscopic and/or endoscopic approach",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "first-line depot SSA treatment",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "available follow-up after 60 months of treatment",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "dopamine-agonists or pegvisomant",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "s.c. octreotide for longer than 15 days",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "radiotherapy",
      "label": "not_met",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has a history of acromegaly due to pituitary adenoma and underwent transsphenoidal surgery. He takes vitamin D and multivitamins post-surgery.",
  "_meta": {
    "topic_id": "56",
    "trial_id": "NCT00703079",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}